Vir Biotechnology Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.2% | -6.5% | -6.9% | -10.3% | -6.6% | -6.5% | -8.8% | -14.5% | -1.6% | +2.3% | +18.5% | |
| – | -10.2% | -23.6% | -0.6% | -13.2% | -0.4% | -10.6% | -21.1% | -25.8% | -5.8% | +1.7% | +9.7% | |
| – | -46.6% | -33.5% | +84.7% | -43.3% | +32.4% | +22.7% | -22.8% | -19.4% | +37.6% | +17.9% | +1.0% | |
| – | -10.3% | -24.5% | +0.1% | -20.6% | -1.0% | -11.5% | -24.4% | -16.4% | -8.6% | +2.1% | +11.9% | |
| – | +141.7% | -15.5% | -26.5% | -26.4% | -3.8% | – | – | -23.1% | -10.0% | – | – | |
| – | – | – | – | -530,000,100.0% | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | 0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -11.3% | -0.6% | -15.9% | +1.9% | -57.9% | -0.3% | -0.9% | -0.9% | -0.9% | -0.9% | -1.0% | |
| – | -11.1% | -25.0% | -4.4% | +9.2% | -3.6% | +6.2% | -7.1% | -8.9% | +6.4% | -10.4% | +9.2% | |
| – | +6.3% | -46.4% | +2.5% | +21.5% | +2.1% | +14.7% | -23.5% | -28.4% | +23.4% | -20.7% | +29.1% | |
| – | -5.1% | -7.4% | +63.6% | -0.4% | -60.1% | +2.2% | +11.4% | +1.5% | -1.8% | +1.7% | +2.2% | |
| – | +74.6% | +12.3% | -38.3% | +66.4% | -30.4% | -26.7% | +228.4% | -44.0% | +43.2% | -44.5% | +226.1% | |
| – | -5.1% | -2.7% | -7.3% | -13.5% | -7.3% | -9.3% | -9.2% | -16.0% | -3.9% | +6.2% | +20.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +0.5% | +0.7% | +0.3% | +0.1% | +0.5% | +0.7% | +0.3% | +0.2% | +5.8% | +14.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.